Starpharma Holdings Ltd. ADS (SPHRY) Financials No
Post# of 250675
Posted On: 11/17/2014 3:17:04 AM
Starpharma Holdings Ltd. ADS (SPHRY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Starpharma Holdings Ltd. ADS
Fiscal year is July-June. All values AUD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1.4M 1.12M 881,000 840,000 273,000
Cost of Goods Sold (COGS) incl. D&A - - - - -
COGS excluding D&A - - - - -
Depreciation & Amortization Expense 1.7M 1.53M 1.14M 1.05M 1.1M
Depreciation 227,000 172,000 134,000 159,000 153,000
Amortization of Intangibles 1.47M 1.36M 1.01M 891,000 943,000
Gross Income - - - - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 10.57M 10.69M 15.41M 6.6M 19.01M
Research & Development 5.72M 5.99M 12.09M 3.51M 15.21M
Other SG&A 4.85M 4.7M 3.32M 3.1M 3.79M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 -
EBIT after Unusual Expense 0 0 0 0 -
Non Operating Income/Expense 0 1.2M 204,000 25,000 7,000
Non-Operating Interest Income 699,000 981,000 1.82M 1.57M 973,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 18,000 16,000 8,000 9,000 7,000
Gross Interest Expense 18,000 16,000 8,000 9,000 7,000
Interest Capitalized 0 0 0 0 0
Pretax Income (6.38M) (8.93M) (13.66M) (5.23M) (18.86M)
Income Tax (3,000) 0 0 0 (4.22M)
Income Tax - Current Domestic 5,000 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (8,000) 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 4.22M
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
EPS (Basic) (0.03) (0.04) (0.05) (0.02) (0.05)
Basic Shares Outstanding 225.55M 242.56M 267.65M 283.28M 284.41M
EPS (Diluted) (0.03) (0.04) (0.05) (0.02) (0.05)
Diluted Shares Outstanding 225.55M 242.56M 267.65M 283.28M 284.41M
EBITDA (9.17M) (9.56M) (14.53M) (5.76M) (18.73M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Starpharma Holdings Ltd. ADS
Fiscal year is July-June. All values AUD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1.4M 1.12M 881,000 840,000 273,000
Cost of Goods Sold (COGS) incl. D&A - - - - -
COGS excluding D&A - - - - -
Depreciation & Amortization Expense 1.7M 1.53M 1.14M 1.05M 1.1M
Depreciation 227,000 172,000 134,000 159,000 153,000
Amortization of Intangibles 1.47M 1.36M 1.01M 891,000 943,000
Gross Income - - - - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 10.57M 10.69M 15.41M 6.6M 19.01M
Research & Development 5.72M 5.99M 12.09M 3.51M 15.21M
Other SG&A 4.85M 4.7M 3.32M 3.1M 3.79M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 -
EBIT after Unusual Expense 0 0 0 0 -
Non Operating Income/Expense 0 1.2M 204,000 25,000 7,000
Non-Operating Interest Income 699,000 981,000 1.82M 1.57M 973,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 18,000 16,000 8,000 9,000 7,000
Gross Interest Expense 18,000 16,000 8,000 9,000 7,000
Interest Capitalized 0 0 0 0 0
Pretax Income (6.38M) (8.93M) (13.66M) (5.23M) (18.86M)
Income Tax (3,000) 0 0 0 (4.22M)
Income Tax - Current Domestic 5,000 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (8,000) 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 4.22M
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.38M) (8.93M) (13.66M) (5.23M) (14.64M)
EPS (Basic) (0.03) (0.04) (0.05) (0.02) (0.05)
Basic Shares Outstanding 225.55M 242.56M 267.65M 283.28M 284.41M
EPS (Diluted) (0.03) (0.04) (0.05) (0.02) (0.05)
Diluted Shares Outstanding 225.55M 242.56M 267.65M 283.28M 284.41M
EBITDA (9.17M) (9.56M) (14.53M) (5.76M) (18.73M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)